The immune response to cardiopulmonary bypass

Current Opinion in Anaesthesiology

Volumn 9, Issue 1, 1996, Pages 76-80

  Bastien, Olivier ^a   Piriou, Vincent ^a  

^a LOUIS PRADEL HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; CYTOKINE; STEROID;

BIOCOMPATIBILITY; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; DIGESTIVE SYSTEM INJURY; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; LEUKOCYTE ACTIVATION; METHODOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REPERFUSION; SHORT SURVEY;

EID: 0029929512     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-199602000-00015     Document Type: Short Survey

References (48)

1. Christman JW, Holden EP, Blackwell TS: Strategies for blocking the systemic effects of cytokines in the sepsis syndrome. Crit Care Med 1995, 23:955-963. A review of therapeutic interventions in the field of inflammatory response syndrome. Some of them could be tried in cardiac surgery, with well designed randomized trials. Problems and risks occurring after blocking cytokines or their receptors are presented.
2. Marty C, Misset B, Tamion F, Fitting C, Carlet J, Cavaillon JM: Circulating IL-8 concentrations in patients with multiple organ failure of septic and non septic origin. Crit Care Med 1994, 22: 673-679.
3. Lin RY, Astiz ME, Saxon JC, Saha DC, Rackow DC: Relationships between plasma cytokine concentrations and leukocyte functional antigen expression in patients with sepsis. Crit Care Med 1994, 22:1595-1602.
4. Finn A, Naik S, Klein N, Levinsky RJ, Strobel S, Elliot M: Interleukine-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993, 105:234-241.
5. Jorens PG, De Jongh R, De backer W, Van Damme J, Van Overveld F, Bossaert L, Walter P, Herman AG, Rampart M: IL-8 production in patients undergoing cardiopulmonary bypass. The influence of pretreatment with methylprednisolone. Am Rev Respir Dis 1993, 148:890-895.
6. Moat NE, Rebuck N, Shore DF, Evans TW, Finn AH: Humoral and ecllular activation in a simulated extracorporeal circuit. Ann Thorac Surg 1993, 56:1509-1514.
7. Mathew JP, Rinder CS, Tracey JB, Auszura LA, O'Connor T, Davis E, Smith BR: Acadesine inhibits neutrophil CD-11b up-regulation in vitro and during in vivo cardiopulmonary bypass J Thorac Cardiovasc Surg 1995, 109:448-456.
8. Levy JH, Kelly AB: Inflammation and cardiopulmonary bypass [Editorial]. Can J Anesth 1993, 40:1009-1015.
9. Moat NE, Shore DF, Evans TW: Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins. Eur J Cardiothorac Surg 1993, 7:563-573.
10. Gillinov A, Winkelstein J, Herskowitz A, Cameron D: Letter to the Editor. Ann Thorac Surg 1994, 57:781-786.
11. Butler J, Pillai R, Rocker GM, Westaby S, Parker D, Shale DJ: Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. J Thorac Cardiovasc Surg 1993, 105:25-30.
12. Seghaye MC, Duchateau J, Grabitz G, Faymonville ML, Messmer BJ, Buro Rastmann K, Von Bemuth G: Complement activation during cardiopulmonary bypass in infants and children. Relation to multiple system organ failure. J Thorac Cardiovasc Surg 1993, 106: 978-987.
13. Shimada M, Winchurch RA, Beloucif S, Robotham JL: Effects of anesthesia and surgery on plasma cytokine levels. J Crit Care 1993, 8:109-116.
14. Zuckerberg A, Goldberg L, Lederman H: Effects of hypoxia on interleukin-2 mRNA expression by T lymphocytes. Crit Care Med 1994, 22:203.
15. Tabardel Y, Duchateau J, Schmartz D, Marecaux G, Shahla M, Barvais L, Leclerc JL, Vincent JL: Corticosteroids increase blood IL-10 levels during cardiopulmonary bypass in men. Surgery 1996 (in press).
16. Naldini A, Borelli E, Giomarelli P, Toscano M: In vitro cytokine production and T cell proliferation in patients undergoing CPB. Cytokine 1995, 7:165-170.
17. Deng MC, Wiedner M, Erren M, Mollhoff T, Assmann G, Scheid HH: Arterial and venous cytokine response to cardiopulmonary bypass for low risk CABG and relation to hemodynamics. Eur J Cardio Thorac Surg 1995, 9:22-29.
18. Steinberg JB, Kapelanski DP, Olson JD, Weiler JM: Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993, 106:1008-1016.
19. Gu YJ, van Oeveren W, Akkerman C, Boonstra PW, Huyzen RJ, Wildevuur CRH: Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993, 55:917-922.
20. Watarida S, Mori A, Onoe M, Tabata R, Shiraishi S, Sugita T, Nojima T, Nakajima Y, Matsuno S: A clinical study on the effects of pulsatile cardiopulmonary bypass on the blood endotoxin levels. J Thorac Cardiovasc Surg 1994, 108:620-625.
21. Johnson D, Thomson D, Myck T, Burbridge B, Mayers I: Depletion of neutrophils by filter during aortocoronary bypass surgery transiently improves postoperative cardiorespiratory status. Chest 1995, 107:1253-1259.
22. Wachtfogel YT, Kucich U, Hack CE, Gluszko P, Niewwiarowski S, Colman RW, Edmunds LH: Aprotinin inhibits the contact neutrophil, and platelet activation systems during stimulated extracorporeal perfusion. J Thorac Cardiovasc Surg 1993, 106:1-10.
23. Boldt J, Osmer C, Schindler E, Linke LC, Stertmann WA, Hempelmann G: Circulating adhesion molecules in cardiac operations: influence of high-dose aprotinin. Ann Thorac Surg 1995, 59:100-105.
24. Menasche P, Haydar S, Peynet J, Du Buit C, Merval R, Bloch G, Piwnica A, Tedgui A: A potential mechanism of vasodilation after warm heart surgery. The temperature-dependent release of cytokines. J Thorac Cardiovasc Surg 1994, 107:293-299.
25. Frering B, Philip I, Dehoux M, Rolland C, Langlois JM, Desmonts JM: Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994, 108: 636-641.
26. Journois D, Pouard P, Greely WJ, Mauriat P, Vouhé P, Safran D: Hemofiltration during cardiopulmonary bypass in pediatric cardiac surgery. Effects on hemostasis, cytokines, and complement components. Anesthesiology 1994, 81:1181-1189.
27. Baue AE: The role of the gut in the development of multiple organ dysfunction in cardiothoracic patients. Ann Thorac Surg 1993, 55:822-829.
28. Baue AE: Multiple progressive or sequential systems failure: a syndrome of the 70s. Arch Surg 1975, 110:779-781.
29. Andersen LW, Landon L, Baek L, Jansen E, Baker S: Association between gastric intramucosal pH and splanchnic endotoxin antibody to endotoxin and TNF-α concentrations in patients undergoing CPB. Crit Care Med 1993, 21:210-217.
30. Hall T: The pathophysiology of cardiopulmonary bypass. The risks and benefits of hemodilution. Chest 1995, 107:1125-1133.
31. Martinez Pellus A, Merino P, Bru M, Conejero R, Seller G, Munoz C, Gonzalez G, Alvarez B: Can selective digestive decontamination avoid the endotoxemia and cytokine activation promoted by cardiopulmonary bypass? Crit Care Med 1993, 21:1684-1690.
32. Kawamura T, Wakusawa R, Okada R, Inada S: Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of IL-8 and 6 in reperfusion injury. Can J Anesth 1993, 40:1016-1021.
33. Hennein H, Ebba H, Rodriguez J, Merrick S, Keith F, Bronstein M, Leung J, Mangano D, Greenfield L, Rankin J: Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 1994, 108:626-635.
34. McGrath LB, Locke M, Cane M, Chen C, Ianuzzo CD: Heat shock protein (HSP 72) expression in patients undergoing cardiac operations. J Thorac Cardiovasc Surg 1995, 109:370-376. In the conflicting data about myocardial protection during cardiac surgery, and preconditioning, HSP is a new factor. This work discusses the possible implications and function of HSP. HSP is increased preoperatively in cardiac patients.
35. Robinson BL, Morita T, Toft DO, Morris JJ: Accelerated recovery of post ischemic stunned myocardium after induced expression of myocardial heat-shock protein (HSP 70). J Thorac Cardiovasc Surg 1995, 109:753-764.
36. Moliterno R, Woan M, Bentlejewski C, Qian J, Zeevi A, Pharm S, Griffith P, Duquesnoy R: Heat schock Protein induced T lymphocyte proliferation from endomyocardial biopsies in heart transplantation. J Heart Lung Transplant 1995, 14:329-337.
37. Jansen NJ, van Oeveren W, van Vliet M, Stoutenbeek CP, Eysman L: The role of different types of corticosteroids on the inflammatory mediators in cardiopulmonary bypass. Eur J Cardiothorac surg 1991, 5:211-217.
38. Jansen NJ, van Oeveren, Broek L, Oudemans Van Straaten HM, Stoutenbeek CP, Njoek Joen M, Roozendaal KJ, Eysman L, Wildevuur CRH: Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass. J Thorac Cardiovasc Surg 1991, 102:515-525.
39. Cooper PD, Moat NE: Letters to the editor. J Thorac Cardiovasc Surg 1994, 107:621.
40. Karlstad MD, Patteson SK, Guszcza J, Langdon R, Chesney JT: Methylprednisolone does not influence endotoxin translocation during cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1993, 7:23-27.
41. Markewitz A, Faist E, Lang S, Endres S, Fuchs D, Reichert B: Successful restoration of cell mediated immune response after cardiopulmonary bypass by immunomodulation. J Cardiovasc Surg 1993. 105:15-24.
42. Haeffner Cavaillon N, Rousselier N, Ponzio O, Carreno MP, Laude M, Carpentier A, Kazatchkine MD: Induction of interleukine-1 production in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1989, 98:1100-1106.
43. Pertilla J, Salo M, Pirtikangas CO, Jalonen J, Vainio O: Effects of cardiopulmonary bypass on lymphocytes and their subset counts with or without use of autotransfusion devices. J Thorac Vasc Anesth 1994, 8:532-535.
44. DePalma L, Yu M, McIntosh C, Swain J, Davey R: Changes in lymphocyte subpopulations as a result of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1991, 101:240-244.
45. Bland L, Villarino M, Arduino M, McAllister S, Gordon S, Uyeda C, Valdon C, Potts D, Jarvis W, Favero M: Bacteriological and endotoxin analysis of salvaged blood used in autologous transfusions during cardiac operations. J Thorac Cardiovasc Surg 1992, 103:582-588.
46. Hisatomi K, Masanobu N, Isomura T, Kosuga K, Itoh K: Effects of recombinant erythropoietin on peripheral T lymphocytes. J Thorac Cardiovasc Surg 1995, 109:809. This brief communication about the immunological consequences of erythropoietin suggests that other studies are rapidly needed before extensive use of this product is made.
47. Hayashi H, Nishiushi T, Tamura H, Takeda K: Transfusion associated graft-versus-host disease caused by leukocyte-filtered stored blood. Anesthesiology 1993, 79:1419-1421.
48. Schmand JF, Ayala A, Chaudry IH: Effects of trauma, duration of hypotension and resuscitation regimen on cellular immunity after hemorrhagic shock. Crit Care Med 1994, 22:1076-1082.